Given the association of LSD1 expression with more aggressive types of breast cancer that tend, frequently, to respond poorly to standard treatment and develop therapy resistance, we reasoned that LSD1 might play a role in rendering neoplastic cells less sensitive to drugs. Here, KDM1A is linked to breast carcinoma.